Misperos, Gabriel M.
HRN: 26-54-30 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/16/2025
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
01/16/2025
01/22/2025
IV
275 Mg
Q8H
PCAP C
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes